Cadrenal Therapeutics Inc. (NASDAQ: CVKD) Stock Information | RedChip

Cadrenal Therapeutics Inc. (NASDAQ: CVKD)


$16.0600
-0.1100 ( -0.47% ) 0.0K

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Market Data


Open


$16.0600

Previous close


$16.1700

Volume


0.0K

Market cap


$26.82M

Day range


$16.1350 - $16.1350

52 week range


$5.4000 - $32.5500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 19, 2024
4 Insider transactions 1 Jan 19, 2024
4 Insider transactions 2 Jan 19, 2024
4 Insider transactions 1 Jan 19, 2024
4 Insider transactions 1 Jan 19, 2024

Latest News